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Organotin compounds are widely distributed toxicants. They are membrane-active molecules with broad biological toxicity. In this contribution,
we study the effect of triorganotin compounds on membrane permeability using phospholipid model membranes and human erythrocytes.
Tribultyltin and triphenyltin are able to induce the release of entrapped carboxyfluorescein from large unilamellar vesicles. The rate of release is
similar for phosphatidylcholine and phosphatidylserine systems and the presence of equimolar cholesterol decreases the rate of the process. Release
of carboxyfluorescein is almost abolished when a non-diffusible anion like gluconate is present in the external medium, and it is restored by addition
of chloride. Tributyltin is able to cause hemolysis of human erythrocytes in a dose-dependent manner. Relative kinetics determination shows that
potassium leakage occurs simultaneously with hemoglobin release. Hemolysis is reduced when erythrocytes are suspended in a gluconate medium.
These results indicate that triorganotin compounds are able to transport organic anions like carboxyfluorescein across phospholipids bilayers by
exchange diffusion with chloride and suggest that anion exchange through erythrocyte membrane could be related to the process of hemolysis.
© 2005 Elsevier B.V. All rights reserved.Keywords: Organotin compound; Carboxyfluorescein release; Model membrane; Hemolysis1. Introduction
Triorganotin compounds are used extensively as stabilizers
in the production of plastic, agricultural pesticides, preserva-
tives of paper and textiles and antifoulant paints [1,2]. The high
biological activity of these compounds towards aquatic organ-
isms has a deleterious impact on aquatic ecosystems [3]. The
toxicity of triorganotin compounds is very broad, they cause
neurotoxicity in animals and humans [4] and are known to have
detrimental effects on the immune response [5].
The extensively used triorganotin compounds tributyltin
(TBT) and triphenyltin (TPT) are two of themost toxic species to
mammalian cells. These compounds are membrane active
molecules, and their mechanism of action appears to be strongly
dependent on organotin lipophilicity [6,7]. They function as
ionophores [8] and produce hemolysis [7], release of calcium
from sarcoplasmic reticulum [9], alteration of phosphatidylser-Abbreviations: CF, carboxyfluorescein; CHOL, cholesterol; FITC, fluores-
cein isothiocyanate; PC, phosphatidylcholine; PS, phosphatidylserine; TBT, tri-
n-butyltin chloride; TPT, tri-n-phenyltin chloride
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doi:10.1016/j.bbamem.2005.12.005ine-induced histamine release [10], alteration of mitochondrial
membrane permeability [11], perturbation of membrane en-
zymes [12,13], and induction of apoptosis in lymphocytes [14].
Organotin compounds have been shown to affect cell signalling,
they activate protein kinase C [15] and increase free arachidonic
acid through the activation of phospholipase A2 [16].
Hydrophobicity of organotin compounds suggests that inter-
action with membranes may play an important role in their toxic
mechanism. In this respect, the understanding of the interaction
between organotin compounds and the lipid component of
membranes is of considerable interest. TBT has been shown to
affect the thermotropic properties of dipalmitoylphosphatidyl-
choline, suggesting a location of the toxicant in the hydrophobic
region of the membrane [17,18]. Triorganotin compounds affect
the degree of hydration of the carbonyl moiety of phosphati-
dylcholine systems [19], they promote the formation of non-
lamellar phases in unsaturated phosphatidylethanolamines [20]
and disorder the packing of phosphatidylserine bilayers [21].
In order to get insight into the mechanism of the toxic action
of triorganotin compounds, we present a study of the effect of
these toxicants on the permeability of different phospholipid
membranes and extent the study to the hemolitic activity of these
compounds.
Fig. 1. Time dependence of TBT induced release of CF from phosphatidylcho-
line vesicles. TBT was added to a phosphatidylcholine vesicle suspension (25
μM) at different concentration, from top to bottom: 1.31, 0.38, 0.25, 0.17, 0.12,
0.07, 0.02 μM.
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2.1. Materials
Egg yolk L-α-Lecithin (phosphatidylcholine, PC) and bovine brain
phosphatidylserine (PS) were obtained from Avanti Polar Lipids (Birminham,
AL). Cholesterol, 5(6)-Carboxyfluorescein (CF), tri-n-butyltin chloride (TBT),
tri-n-phenyltin chloride (TPT), and FITC-dextrans were obtained from Sigma-
Aldrich (Spain). All other reagents were of the highest purity available. Twice-
distilled and deionized water was used. Stock solution of lipids were prepared in
chloroform/methanol (1:1) and stored at −20 °C.
2.2. Release of vesicle contents
Vesicles were prepared by combining the appropriate amount of lipids in
chloroform/methanol (1:1). Organic solutions were dried under a stream of N2
and last traces of solvent were removed by 3 h desiccation under high vacuum.
To the dry samples, 1 ml of a medium containing 50 mM CF, 5 mM HEPES pH
7.4 was added and multilamellar vesicles were formed by vortexing the mixture.
Large unilamellar vesicles were prepared by repeated extrusion of the
multilamellar vesicles through polycarbonate filters (Nuclepore, 0.1 μm pore
size) using a LiposoFast (Avestin, Inc, Canada). Vesicles were separated from
nonencapsulated CF by gel filtration on Shephadex G-50, using 100 mM NaCl
(or potassium gluconate when indicated), 0.1 mM EDTA, 5 mM HEPES pH 7.4
as elution buffer. Lipid vesicle samples were analyzed for phospholipid
phosphorous according to the method of Böttcher [22].
Release of CF was measured at 25 °C in a Biotek SFM-25 spectrofluorom-
eter. Excitation and emission wavelengths were 430 and 520 nm, respectively.
For calibration of the fluorescence scale, maximum release was induced by
lysing the vesicles with 1% Triton X-100. TBTor TPTwere added to the vesicle
suspensions in buffer from a stock solution in DMSO. The volume of DMSO
added was always less than 5% of the total buffer volume and control
experiments showed that DMSO by itself did not produce any release.
2.3. Erythrocytes
Human erythrocytes were freshly prepared right before the experiments from
just outdated red blood cell concentrates obtained from a local blood bank. Cells
were washed twice with buffer (150 mM NaCl or potassium gluconate when
indicated, 5 mM HEPES, pH 7.4), and finally suspended in this same buffer at a
hematocrit of 24%. All the operations were carried out at 4 °C.
2.4. K+ leakage and hemolysis
The leakage of K+ from erythrocytes was measured using a K+ selective
electrode (Jenway, UK) as follows. Erythrocytes were suspended in 10 ml of 150
mMNaCl, 5 mMHEPES, pH 7.4 at a hematocrit of 0.36%. TBTwas added from
a stock solution in DMSO (the volume of DMSO added was always less than
0.5% of the total buffer volume and control experiments showed that DMSO by
itself did not produce any hemolysis), and the potassium efflux was continuously
monitored using a recorder. The total amount of K+ was determined by disrupting
the cells with sodium cholate. The solutions were continuously stirred using a
magnetic device. Measurements were done in a jacketed vessel and temperature
was kept constant at 37 °C using a circulating water bath. Upon addition of TBT
under different conditions as indicated, hemolysis was determined by measuring
the absorbance of released hemoglobin at 540 nm after pelleting the membranes
by centrifugation for 2 min in a bench microfuge. The total amount of
hemoglobin was established by lysing the erythrocytes with water.3. Results and discussion
3.1. Release of carboxyfluorescein from phospholipid vesicles
The ability of TBT to induce release of CF from phospha-
tidylcholine vesicles is shown in Fig. 1. Low μM concentrationsof TBT, corresponding to molar fractions of TBT ranging from
0.01 to 0.1, produced a rapid release of CF which was complete
within seconds for samples containing a TBT concentration
higher than 1 μM.
Fig. 2 shows the initial rate of CF release from vesicles of
different phospholipid composition after addition of TBT. Initial
rates of CF release were very similar for vesicles composed by
phosphatidylcholine and phosphatidylserine, while the presence
of cholesterol (1:1) produced a drastic decrease. The inset of
Fig. 2 shows the time course of CF release after addition of 0.51
μM TBT. Considering that phosphatidylcholine is a neutral
phospholipid and phosphatidylserine bears a negative charge at
pH 7.4, it seems that the composition of the polar head group of
the phospholipid is not important for the mechanism of release
of entrapped CF. It has been suggested that triorganotin com-
pounds are located in the upper part of the hydrophobic region
of the membrane [17,19,23] where cholesterol is also located.
The effects of cholesterol on membrane permeability are well
established [24]. Two parameters have been identified which are
related to structural discontinuities and defects in the lipid
bilayer. These factors are related to the “free volume” in which
small permeating molecules can reside and move with this free
volume [25]. At the molecular level, there are kinks formed due
to trans-gauche isomerization which runs along the hydro-
carbon chain, and at the lateral organization level, there are
membrane defects formed at the phase boundary under con-
ditions that lateral phase separation occurs [26]. The presence of
cholesterol in the membrane minimizes free volume, thereby
reducing membrane permeability [27]. These effects could
explain the observed reduction of CF release in the presence of
cholesterol.
TPT was also able to release CF from phospholipid vesicles
and similar qualitatively results were obtained concerning the
presence of cholesterol (not shown). It is interesting to observe
that for any given triorganotin concentration the release of CF in
the presence of TPT was an order of magnitude less efficient
than in the presence of TBT. The latter is in accordance with the
observation that TPT is less toxic [28] and induces less drastic
lesions [29] than TBT.
Fig. 4. Time dependence of CF release from phosphatidylcholine vesicles (25
μM) placed in a medium containing gluconate after addition of TBT and
subsequent addition of chloride. (1) Initial addition of TBT (0.25 μM); (2)
subsequent addition of sodium chloride at different concentration, from top to
bottom: 100, 50, 16.6 and 3.3 mM.
Fig. 2. Effect of increasing concentration of TBT on the initial rate of CF release
from phospholipid vesicles (25 μM) of different composition, phosphatidylser-
ine (●), phosphatidylcholine (○), and phosphatidylcholine/ cholesterol (1:1)
(□). Data were fitted by linear regression using Microcal Origin 5.0 software.
The inset shows the time dependence of CF release from phospholipid vesicles
of different composition after addition of TBT (0.51 mM), phosphatidylserine
(PS), phosphatidylcholine (PC) and phosphatidylcholine/cholesterol (1:1)
(PC/CHOL).
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from phospholipid vesicles
It is known that triorganotin compounds can mediate ex-
change diffusion of halides and other inorganic anions across
biological and model membranes [8,30,31]. To test the possi-
bility that the organic anion, CF, which is encapsulated inside
phospholipid vesicles, could be released through exchange dif-
fusion with external chloride, we measured release of CF under
two different conditions: samples with chloride present in the
external medium and samples in which chloride was replaced
by gluconate. Fig. 3 clearly shows that in the absence of chlo-
ride and in the presence of gluconate, there is almost no release
of CF from phosphatidylcholine vesicles. Similar qualitativelyFig. 3. Effect of increasing concentration of TBTon the initial rate of CF release
from phosphatidylcholine vesicles (25 μM) placed in a medium containing
chloride (●) or gluconate (▪). Data were fitted by linear regression using
Microcal Origin 5.0 software. The inset shows the time dependence of CF release
from phosphatidylcholine vesicles placed in a medium containing chloride
(curve a) or gluconate (curve b) after addition of TBT (0.25 μM).results were obtained for TPT samples (not shown). The ad-
dition of chloride to the external medium containing gluconate
restored the ability to release encapsulated CF, the rate of release
being dependent of the concentration of added chloride (Fig. 4).
TBT is able to exchange chloride and CF, but as shown in Fig. 5,
this exchange is not produced when a larger molecule, like
FITC-dextran, is encapsulated inside the vesicles. These results
indicate that triorganotin compounds are able to transport
organic anions across the lipid bilayer by a mechanism of
exchange diffusion with chloride.
In order to test the possibility that transport through ex-
change diffusion with chloride could be related to the known
hemolytic ability of TBT, we will next characterize the release
of hemoglobin after TBT addition and then study the effect of a
non-diffusible anion on the process.Fig. 5. Effect of TBT on time dependence of release of contents from
phosphatidylcholine vesicles (50 μM) containing CF (curve a), FITC-dextran 4
(curve b), and FITC-dextran 10 (curve c). (1) Addition of TBT (1.31 μM) and
(2) addition of triton X-100.
Fig. 6. Dependence of the relative hemolysis of human erythrocytes on the
concentration of TBT, at different incubation times: 3 min (▪), 7 min (●) and
11 min (▴).
Fig. 8. Relative kinetics of K+ leakage (continuous solid line) and hemolysis (●,
dashed) induced by TBT (5 μM).
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The ability of triorganotin compounds to cause hemolysis of
human and other species erythrocytes has been reported before
[28,32,33]. The kinetics of TBT induced hemolysis has been
described to be very different depending on the erythrocyte
species, whether whole blood or red cells concentrate are used,
and also on the effective concentration of erythrocytes in the
incubation mixture. The dependence of hemolysis on TBT
concentration at different incubation times is presented in Fig. 6.
It is seen that low μM concentration of TBT produced a
relatively fast liberation of hemoglobin which was complete
within 10 min.
Upon interaction with erythrocytes, TBT also induced the
leakage of K+ ions in a concentration dependent manner. Initial
rates of K+ leakage were obtained and they are shown in Fig. 7.
It can be seen that increasing concentration of TBT produced anFig. 7. Effect of increasing concentration of TBTon the initial rate of K+ leakage
from erythrocytes. Data were fitted by linear regression using Microcal Origin
5.0 software.increase in the initial rate of K+ leakage, showing a linear
dependence with no saturation in the range of TBT under study.
The relative kinetics of K+ leakage and hemolysis of human
erythrocytes were measured and compared (Fig. 8). As shown
in this figure, the K+ leakage curve resulting from incubation of
erythrocyte suspension with 5 μM TBT is very close to the
hemolysis curve. The sigmoidal kinetic pattern has been taken
as an indication of a complex process representing accumula-
tion of sufficient membrane damage to permit leakage of hemo-
globin from cells [34]. Several hemolytic agents, including
melittin [35], ethanol [36] and iturin A [37], have been des-
cribed to cause hemolysis by the colloid-osmotic mechanism.
These agents form pores or small lesions in the membrane
producing the rapid leakage of K+, water enters due to the
osmotic gradient created by hemoglobin trapped inside, the
erythrocyte swells, further damage occurs and finally hemo-
globin is lost. The similar rate of K+ leakage and hemoglobin
release observed if Fig. 8 strongly excludes the formation of
pores and consequent colloid-osmotic lysis. Rather, the results
support the concept or TBT-induced hemolysis via direct mem-
brane disruption. It has been reported that organotin compounds
induce erythrocyte shape transformation and form tin-Fig. 9. Dependence of the relative hemolysis of human erythrocytes after
addition of TBT (5 μM) in chloride (●) or gluconate (▪) buffer.
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been associated with hemolysis [38].
Erythrocyte membrane disruption is in contrast with the lack
of membrane alteration described above for model membranes.
This may reflect the more complex nature of the red cell as
compared to phospholipid vesicles. The different erythrocyte
membrane composition and the presence of several ions and
osmotic active molecules like hemoglobin into the erythrocyte
aqueous inner space may be the cause of the distinct response to
TBT.
The detailed mechanism for TBT induced hemolysis has not
been determined. It has been proposed that a rapid ATP deple-
tion, possibly due to inhibition of membrane calcium or
sodium–potassium pumps, could produce a rapid erythrocyte
shape transformation followed by lysis [39]. TBT has been
claimed to disrupt the cytoskeletal–lipid bilayer interactions
leading to shape transformation and lysis [40]. The possibility
that TBT could act producing free radicals resulting in
membrane alteration and lysis has also been presented [41].
Hemolysis was measured with erythrocytes suspended in
medium with a non-diffusible anion, gluconate, and compared
with those suspended in a medium with chloride. Fig. 9 shows
that relative hemolysis is decreased when erythrocytes were in a
medium in the absence of chloride, suggesting a protective role
for gluconate against TBT induced hemolysis. We have
described above that the protective effect of gluconate against
CF release from phospholipids vesicles can be reversed by the
presence of chloride. Although the possibility of an electrostatic
interaction between TBTand gluconate which could prevent the
interaction of TBT with the erythrocyte membrane cannot be
ruled out, the results suggest that gluconate may protect eryth-
rocyte from hemolysis simply because it cannot be easily
transported across the membrane. The data suggest that tran-
sport of anions across the membrane could be related to the
mechanism of hemolysis. Organic and inorganic anion transport
across the erythrocyte membrane may alter ionic gradients and
led to the reported shape transformation and lysis, producing the
simultaneous release of hemoglobin and K+. Whether anionic
transport is the primary event in hemolysis or it acts com-
plementing other proposed mechanisms will require further
study.
4. Concluding remarks
In this work, we have shown that triorganotin compounds are
able to transport organic anions across the phospholipid bilayer
through an exchange diffusion mechanism with chloride. This
transport is not affected by the nature of the polar head group of
the phospholipids, but it is reduced by the presence of cho-
lesterol which could make the diffusion of triorganotin com-
pounds more difficult given its known permeability-decreasing
effect on membranes. The study of the hemolytic activity of
TBT showed that the toxicant induces the release of hemoglobin
from erythrocytes at a similar rate that the release of K+ which
indicates that TBT is not forming small lesions in the mem-
brane. The results suggest that anion transport might be related
to the hemolysis mechanism.References
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